Research Article
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Table 1
Characteristics of patients with COVID-19.
| | Demographic | Clinical classifications on admission | Outcome at composite endpoint | | Mild/ordinary cases | Severe cases | Critical cases | Total | Hospital discharge | Improved | Exacerbation | Death | Total |
| Age, years
() | | | | | | | | | | | Distribution, (%) | | | | | | | | | | | <60 | 20 (17.4%) | 11 (9.6%) | 6 (5.2%) | 37 (32.2%) | 24 (20.9%) | 8 (6.9%) | 1 (0.8%) | 4 (3.5%) | 37 (32.2%) | | ≥60 | 19 (16.5%) | 37 (32.2%) | 22 (19.1%) | 78 (67.8%) | 28 (24.3%) | 24 (20.9%) | 7 (6.1%) | 19 (16.5%) | 78 (67.8%) | | Total | 39 (33.9%) | 48 (41.7%) | 28 (24.3%) | 115 | 52 (45.2%) | 32 (27.8%) | 8 (6.9%) | 23 (0.2%) | 115 | | Gender | | | | | | | | | | | Male, (%) | 20 (17.4%) | 29 (25.2%) | 17 (14.8%) | 66 (57.4%) | 28 (24.3%) | 19 (16.5%) | 7 (6.1%) | 12 (10.4%) | 66 (57.4%) | | Female, (%) | 19 (16.5%) | 19 (16.5%) | 11 (9.6%) | 49 (42.6%) | 24 (20.9%) | 13 (11.3%) | 1 (0.8%) | 11 (9.6%) | 49 (42.6%) | | Total | 39 (33.9%) | 48 (41.7%) | 28 (24.3%) | 115 | 52 (45.2%) | 32 (27.8%) | 8 (6.9%) | 23 (0.2%) | 115 |
|
|
